Evidence map›Paper›PMID 42563700›Full record

ArticleInternational journal of molecular medicine2026

[Corrigendum] Peroxisome proliferator‑activated receptor α regulates acesulfame‑K‑induced NAFLD via hepatic PLCβ: Foe and friend.

Peng-Yao Lin, Jia-Rong Xie, Tian-Chen Qian, Shi-Song Wang, Si-Yi Yu, Wen-Bo Shi, Ying Wang, Lu-Ze Cen, Qing-Jing Zhu, Yi-Yang Zheng and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Inhibition of GPR4 Ameliorates Neuropathic Pain and Neuronal Ferroptosis via Regulation of Spinal RhoA/YAP Signaling in Rats.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Peng-Yao LinDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.
Jia-Rong XieDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.
Tian-Chen QianDepartment of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310027, P.R. China.
Shi-Song WangDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.
Si-Yi YuDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.
Wen-Bo ShiDepartment of Pharmacology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Ying WangDepartment of Pharmacology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Lu-Ze CenDepartment of Pharmacology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Qing-Jing ZhuDepartment of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310027, P.R. China.
Yi-Yang ZhengDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.
Hui GaoDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.
Rong FangNingbo Clinical Pathology Diagnosis Center, Ningbo, Zhejiang 315021, P.R. China.
Zhao-Xia XiaNingbo Clinical Pathology Diagnosis Center, Ningbo, Zhejiang 315021, P.R. China.
Ai-Ming LiuDepartment of Pharmacology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, P.R. China.
Lei XuDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above article, the authors have contacted the Editorial Office to explain that they inadvertently assembled Fig. 5D on p. 9, showing Oil Red O staining of Hepa1‑6 cells following transfection with a plasmid, incorrectly. Specifically, the same data had been included to show the results of the 'FFA‑AK‑1' experiment (top row, panel on the right) and the 'FFA‑AK‑10' experiment (bottom row, panel in the middle). Upon investigating this figure, the authors realized that the data shown correctly for the 'FFA‑AK‑10' experiment had been duplicated to show the results for the 'FFA‑AK‑1' experiment. A revised version of Fig. 5, now showing the correct data panel for the 'FFA‑AK‑1' experiment in Fig. 5D, is shown on the next page. The authors confirm that the error associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of

Indexed as

acesulfame‑Knonalcoholic fatty liver diseaseperoxisome proliferator‑activated receptor αphospholipase C betasweet taste receptor

Identifiers

PMID42563700
PMCPMC13451047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.